Skip To The Main Content
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
Yang Wang
Partner
 
3901 China World Tower A
1 Jian Guo Men Wai Avenue
Beijing 100004 
 
Email:
Phone: +86-10-5965-2976
Fax: +86-10-5965-2988

Representing private equity funds and corporate clients, Yang Wang is a Partner in Simpson Thacher’s Corporate Department. His varied practice includes assisting clients on mergers and acquisitions, private equity transactions, corporate finance transactions and other general corporate matters. Yang was recognized as one of China’s Top 15 M&A Lawyers by Asian Legal Business in 2019 and 2018. Yang has also been recognized by Chambers Asia and The Legal 500 for his work in M&A and private equity. Yang speaks both English and Mandarin Chinese.

Read Full Biography...

Work Highlights
  • New Frontier Corporation in its announced $1.3 billion acquisition of United Family Healthcare
  • Ant Financial in its Series C equity financing totaling approximately US$14 billion
  • China National Chemical Corporation in its acquisition of the Swiss agrochemical and seeds company Syngenta AG for approximately US$43 billion, the largest foreign acquisition by a Chinese company
  • Primavera Capital Group and Ant Financial Services Group in their $460 million investment in Yum China Holdings Inc., concurrent with the completion of Yum China’s spinoff from Yum! Brands, Inc.
  • Alibaba Group in its strategic new retail partnership with Starbucks in China, its US$4.63 billion investment in Suning Commerce Group Limited, one of the largest consumer electronics retail chains in China, and Suning’s US$2.2 billion investment in Alibaba Group
  • MOGU Holdings Limited in its strategic merger with Meiliworks Inc., valuing the combined company at US$3 billion
  • Kuaidi Dache in its strategic stock-for-stock merger with Didi Dache
Education
  • University of Michigan Law School, 2008 J.D.
    magna cum laude; Clarence Darrow Scholar; Article Editor, Michigan Law Review
  • University of Maryland, 2005 M.A. in Applied Mathematics
  • University of Maryland, 2001 B.S. in Mathematics and Computer Science
    magna cum laude
  • University of Maryland, 2000 B.A. in Economics
    summa cum laude
Admissions
  • New York 2009

Yang Wang is a Partner in Simpson Thacher’s Beijing office. He represents private equity funds and corporate clients on various mergers and acquisitions, private equity transactions, corporate finance transactions and other general corporate matters.

Recent representative experience includes advising:

  • New Frontier Corporation in its announced $1.3 billion acquisition of United Family Healthcare
  • KKR in the creation of SinoCare Group, an investment and management platform company, and in its acquisition of a majority stake in HeTian Hospital Management Co.
  • Ant Financial in its Series C equity financing totaling approximately US$14 billion
  • Primavera Capital Group and Ant Financial Services Group in their $460 million investment in Yum China Holdings Inc., concurrent with the completion of Yum China’s spinoff from Yum! Brands, Inc.
  • China National Chemical Corporation in its acquisition of the Swiss agrochemical and seeds company Syngenta AG for approximately US$43 billion, the largest foreign acquisition by a Chinese company
  • Primavera Capital in its acquisition of Iovate Health Sciences, a leading food supplement manufacturer based in Canada, by Primavera Capital and Xiwang Foodstuffs, valuing Iovate at approximately US$730 million
  • Alibaba Group in its strategic new retail partnership with Starbucks in China, its US$4.63 billion investment in Suning Commerce Group Limited, one of the largest consumer electronics retail chains in China, and Suning’s US$2.2 billion investment in Alibaba Group
  • MOGU Holdings Limited in its strategic merger with Meiliworks Inc., valuing the combined company at US$3 billion
  • Alibaba Group and Ant Financial in their investments in Didi Chuxing
  • Kuaidi Dache in its strategic stock-for-stock merger with Didi Dache
  • AVIC Electromechanical Systems Holdings Co., Ltd. in its acquisition of Hilite International, a leading global supplier of highly engineered automotive engine and transmission components, at a transaction value of approximately €473 million (US$645 million)
  • Israel Chemicals Ltd. in its strategic investment in Yunnan Yuntianhua Co., Ltd.
  • Danone Asia Pte. Ltd. in its €480 million investment in Inner Mongolia Mengniu (Group) Co., Ltd. and the related shareholding restructuring transaction involving COFCO and Mengniu

Yang was recognized by Asian Legal Business as one of China’s Top 15 M&A Lawyers in 2019 and 2018. Yang has also been recognized by Chambers Asia and The Legal 500 for his work in M&A and private equity.

Yang received his Bachelor’s degree in Economics, summa cum laude, and Bachelor’s degree in Mathematics and Computer Science, magna cum laude, from the University of Maryland, College Park in 2000 and 2001, respectively. He received his Juris Doctor degree, magna cum laude, from the University of Michigan Law School in 2008, where he was a Clarence Darrow Scholar and served as an Article Editor of the Michigan Law Review. Yang is admitted to practice law in the State of New York. He speaks English and Mandarin Chinese.

News & Events

    Publications